ARCA biopharma Stock (NASDAQ: ABIO) stock price, news, charts, stock research, profile.
Open | $3.26 |
Close | $3.12 |
Volume / Avg. | 67.66K / 99.03K |
Day Range | 3.12 - 3.33 |
52 Wk Range | 1.56 - 4.49 |
Market Cap | $45.82M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 40.26% |
Days to Cover | 75.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ARCA biopharma (NASDAQ:ABIO) through any online brokerage.
Other companies in ARCA biopharma’s space includes: Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX) and CARISMA Therapeutics (NASDAQ:CARM).
There is no analysis for ARCA biopharma.
There is no analysis for ARCA biopharma to provide a consensus price target.
The stock price for ARCA biopharma (NASDAQ: ABIO) is $3.1582 last updated July 23, 2024 at 7:52 PM EDT.
There are no upcoming dividends for ARCA biopharma.
ARCA biopharma’s Q3 earnings are confirmed for Wednesday, October 16, 2024.
There is no upcoming split for ARCA biopharma.
ARCA biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.